Novo Nordisk

(IN BRIEF) A major data-driven study from Aalborg University has found that missing periods of continuous glucose monitor use in people with diabetes are closely linked to poorer blood sugar control — and likely not random. Analyzing sensor data from … Read the full press release →

(IN BRIEF) Novonesis and Novo Nordisk have formed a research partnership to study how the gut microbiome can support metabolic health and help prevent obesity-related complications. The collaboration will explore synbiotic food supplements, combining probiotics and prebiotics, to assess their … Read the full press release →

(IN BRIEF) The University of Copenhagen will open RECAST this August, a large-scale exhibition marking 150 years since women were first admitted to the university. The show brings 13 contemporary artists into dialogue with historical busts of white male scientists … Read the full press release →

(IN BRIEF) Novo Nordisk has received a positive opinion from the European Medicines Agency’s CHMP recommending label expansion for Alhemo® (concizumab) to include adolescents and adults with haemophilia A and B without inhibitors. Backed by robust data from the explorer8 … Read the full press release →

(IN BRIEF) From its leadership of key work packages to its rich data resources—the ESC Atlas of Cardiology and GRASP study—the European Society of Cardiology is driving EuroHeartPath’s mission to transform heart-disease care in Europe. This €27 million Horizon Europe … Read the full press release →

(IN BRIEF) A team of researchers from the University of Copenhagen has revealed groundbreaking findings about insulin resistance, showing that it varies widely on a molecular level even among healthy individuals and those diagnosed with type 2 diabetes. This discovery … Read the full press release →

(IN BRIEF) Researchers from the University of Copenhagen have created “super stem cells” by altering the cells’ diet, enhancing their ability to differentiate into various cell types such as liver, skin, and nerve cells. This development has significant implications for … Read the full press release →

(IN BRIEF) Effective 3 April 2025, Novo Nordisk will undergo key changes in its Executive Management. Camilla Sylvest, a long-time leader with 28 years at the company, has decided to step down. In response, Ludovic Helfgott will assume expanded responsibilities … Read the full press release →